RobertAllanHodgsonMD

Family Medicine • Fort Worth, TX

Physician

Join to view full profile

Are you Dr. Hodgson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 76 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
5445 Basswood Blvd
Suite 650
Fort Worth, TX 76137
Phone+1 817-485-0161

Fax+1 817-485-9430
Is this information wrong?

Summary

Dr. Robert Hodgson, MD is a board certified family physician in Fort Worth, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Medical City North Hills and Baylor Scott & White Institute for Rehabilitation - Dallas.

Education & Training

John Peter Smith Hospital (Tarrant County Hospital District)Residency, Family Medicine, 1982 - 1985
University of Oklahoma College of MedicineClass of 1982

Certifications & Licensure

TX State Medical License 1983 - 2025
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2013

Publications & Presentations

PubMed

5 citations
Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists
Gang Zhou, Robert G. Aslanian, Gallo Gioconda, Tanweer A. Khan, Rongze Kuang, Biju J. Purakkattle, Manuel de Lera Ruiz, Andrew Stamford, Pauline C. Ting, He-Ping Wu, H...> ;Bioorganic & Medicinal Chemistry Letters. 2016 Feb 15
19 citations
Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior
Robert A. Hodgson, Deborra Mullins, Sherry X. Lu, Mario Guzzi, Xiaoping Zhang, Carina J. Bleickardt, Jack D. Scott, Michael W. Miller, Andrew Stamford, Eric M. Parker,...> ;European Journal of Pharmacology. 2014 May 5
6 citations
Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
Karen M. Smith, Susan E. Browne, Srinivasan Jayaraman, Carina J. Bleickardt, Lisa M. Hodge, Edward V. Lis, Leon Yao, Sunday L. Rittle, Nathalie Innocent, Deborra Mulli...> ;European Journal of Pharmacology. 2014 Apr 5
10 citations
MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) a...
Steven M. Grauer, Robert A. Hodgson, Lynn A. Hyde> ;Psychopharmacology. 2014 Apr 1
9 citations
Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model
Carina J. Bleickardt, Tatiana M. Kazdoba, Nicholas Jones, John C. Hunter, Robert A. Hodgson> ;Pharmacology, Biochemistry, and Behavior. 2014 Mar 1
19 citations
A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats
Nicholas Jones, Carina J. Bleickardt, Deborra Mullins, Eric M. Parker, Robert A. Hodgson> ;Brain Research Bulletin. 2013 Sep 1
71 citations
Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction
Andrew Stamford, Jack D. Scott, Sarah W. Li, Babu Suresh D, Dawit Tadesse, Rachael C. Hunter, Yusheng Wu, Misiaszek Jeffrey A, Jared N. Cumming, Eric J. Gilbert, Chunl...> ;ACS Medicinal Chemistry Letters. 2012 Jul 26
16 citations
The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia
Ginny D. Ho, W. Michael Seganish, Ana Bercovici, Deen Tulshian, William J. Greenlee, Rachel Van Rijn, Alan Hruza, Li Xiao, Diane Rindgen, Deborra Mullins, Mario Guzzi,...> ;Bioorganic & Medicinal Chemistry Letters. 2012 Apr 1
17 citations
Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compound.
William T. McElroy, Zheng Tan, Kallol Basu, Shu-Wei Yang, Jennifer Smotryski, Ginny D. Ho, Deen Tulshian, William J. Greenlee, Deborra Mullins, Mario Guzzi, Xiaoping Z...> ;Bioorganic & Medicinal Chemistry Letters. 2012 Feb 1
17 citations
The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia
Ginny D. Ho, Shu-Wei Yang, Jennifer Smotryski, Ana Bercovici, Terry L. Nechuta, Elizabeth M. Smith, William T. McElroy, Zheng Tan, Deen Tulshian, Mckittrick Brian A, W...> ;Bioorganic & Medicinal Chemistry Letters. 2012 Jan 15
33 citations
Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia.
Shu-Wei Yang, Jennifer Smotryski, William T. McElroy, Zheng Tan, Ginny D. Ho, Deen Tulshian, William J. Greenlee, Mario Guzzi, Xiaoping Zhang, Deborra Mullins, Li Xiao...> ;Bioorganic & Medicinal Chemistry Letters. 2012 Jan 1
13 citations
Adenosine A2A Receptor Antagonists Do Not Disrupt Rodent Prepulse Inhibition: An Improved Side Effect Profile in the Treatment of Parkinson's Disease
Carina J. Bleickardt, Abigail LaShomb, Carrie E. Merkel, Robert A. Hodgson> ;Parkinson's Disease. 2012 Jan 1
20 citations
The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): compa...
Sherry X. Lu, Guy A. Higgins, Robert A. Hodgson, Lynn A. Hyde, Robert A. Del Vecchio, Donald H. Guthrie, Tatiana M. Kazdoba, Martha F. McCool, Cynthia A. Morgan, Ana B...> ;European Journal of Pharmacology. 2011 Jul 1
13 citations
Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination
Robert A. Hodgson, Lynn A. Hyde, Donald H. Guthrie, Mary Cohen-Williams, Prescott T. Leach, Tatiana M. Kazdoba, Carina J. Bleickardt, Sherry X. Lu, Eric M. Parker, Geo...> ;Pharmacology, Biochemistry, and Behavior. 2011 Apr 1
69 citations
Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
Robert A. Hodgson, Paul J. Bédard, Geoffrey B. Varty, Tatiana M. Kazdoba, Thérèse Di Paolo, Michael Grzelak, Annamarie Pond, Abdallah Hadj-Tahar, Nancy Bélanger, Laure...> ;Experimental Neurology. 2010 Oct 1
30 citations
Recent progress in the discovery of adenosine A(2A) receptor antagonists for the treatment of Parkinson's disease
Shah Unmesh G, Robert Hodgson> ;Current Opinion in Drug Discovery & Development. 2010 Jul 1
10 citations
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor anatgonists
Scott Jack D, Michael W. Miller, Sarah W. Li, Sue-Ing Lin, Vaccaro Henry A, Liwu Hong, Deborra E Mullins, Mario Guzzi, Jay Weinstein, Robert A. Hodgson, Geoffrey B. Va...> ;Bioorganic & Medicinal Chemistry Letters. 2009 Nov 1
124 citations
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)...
Robert A. Hodgson, Rosalia Bertorelli, Geoffrey B. Varty, Jean E. Lachowicz, Angelo Forlani, Silva Fredduzzi, Mary Cohen-Williams, Guy A. Higgins, Francesco Impagnatie...> ;The Journal of Pharmacology and Experimental Therapeutics. 2009 Jul 1
52 citations
Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior.
C. J. Bleickardt, Deborra E Mullins, C. P. MacSweeney, B. J. Werner, Pond Annamarie, Mario Guzzi, F. D. C. Martin, Geoffrey B. Varty, Robert A. Hodgson> ;Psychopharmacology. 2009 Mar 1
67 citations
The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 22...
Geoffrey B. Varty, Sherry X. Lu, Cynthia A. Morgan, Mary Cohen-Williams, Robert A. Hodgson, April Smith-Torhan, Hongtao Zhang, Ahmad Fawzi, Michael P. Graziano, Ginny ...> ;The Journal of Pharmacology and Experimental Therapeutics. 2008 Aug 1
40 citations
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Geoffrey B. Varty, Robert A. Hodgson, Pond Annamarie, Michael Grzelak, Eric M. Parker, John C. Hunter> ;Psychopharmacology. 2008 Jul 3
44 citations
Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs.
Robert A. Hodgson, Donald H. Guthrie, Geoffrey B. Varty> ;Pharmacology, Biochemistry, and Behavior. 2008 Jan 1
34 citations
The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors
Guy A. Higgins, Michael Grzelak, Pond Annamarie, Mary Cohen-Williams, Robert A. Hodgson, Geoffrey B. Varty> ;Behavioural Brain Research. 2007 Dec 11
13 citations
The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain
Xiao-Wei Dong, Yuping Jia, Sherry X. Lu, Xiaoping Zhou, Mary Cohen-Williams, Robert A. Hodgson, Huiqing Li, Tony Priestley> ;Psychopharmacology. 2007 Sep 23
66 citations
Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
Robert A. Hodgson, Guy A. Higgins, Donald H. Guthrie, Sherry X. Lu, Pond Annamarie, Deborra E Mullins, Mario Guzzi, Eric M. Parker, Geoffrey B. Varty> ;Pharmacology, Biochemistry, and Behavior. 2007 Mar 1
Join now to see all

Press Mentions

A First Look at the Metabolic Rate of Greenland Sharks (Somniosus Microcephalus) in the Canadian ArcticNovember 9th, 2020

Hospital Affiliations

Medical City North HillsNorth Richland Hills, Texas
Baylor Scott & White Institute for Rehabilitation - DallasDallas, Texas